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Persistent organochlorine compounds (POCs)
—for example, polychlorinated dibenzo-p-
dioxins, polychlorinated dibenzofurans
(PCDFs), and polychlorinated biphenyls
(PCBs)—are ubiquitous environmental cont-
aminants. These compounds are highly resis-
tant to both abiotic and biotic degradation,
and thus persistent, and also have high lipid
solubility, which results in bioaccumulation
and biomagniﬁcation in the food chain. The
main human exposure source is the diet, espe-
cially animal fat (Svensson et al. 1991). Most
POCs are highly toxic and have shown a mul-
titude of health effects both in animal experi-
ments and in epidemiologic studies. Animal
studies show that the critical effects of dioxins
and dioxin-like (coplanar) PCBs seem to be
both impaired neurodevelopment and disrup-
tion of reproductive development and func-
tion. Male rats exposed in utero to low doses
of dioxins showed decreased sperm counts
(Faqi et al. 1998; Gray et al. 1997; Mably et
al. 1992). Moreover, in utero exposure to
coplanar PCBs leads to reduced reproductive
capability in the offspring (Brouwer et al.
1995). Adult rats exposed to coplanar PCBs
showed decreased sperm counts and increased
percentages of abnormal spermatozoa (Faqi et
al. 1998). And a recent human study has
shown that in utero exposure to PCBs and to
PCDFs has a deleterious effect on sperm
parameters (Guo et al. 2000).
Reliable biomarkers of POC exposure are
necessary to establish a dose–effect relation-
ship. A PCB congener, 2,2´,4,4´,5,5´-hexa-
chlorobiphenyl (CB-153), is a relevant and
feasible exposure biomarker for POC. CB-
153 in plasma correlated strongly with total
PCB concentration (Atuma et al. 1998;
Grimvall et al. 1997; Hagmar et al. 1998;
Wicklund-Glynn et al. 2000). Furthermore,
CB-153 was well correlated with the 2,3,7,8-
tetrachlorodibenzo-p-dioxin equivalent
(TEQ) in plasma from PCBs (Grimvall et al.
1997), as well as with the total POC-derived
TEQ in plasma (Asplund et al. 1994).
There are indications, although not
unchallenged, that male reproductive func-
tion has deteriorated during the past few
decades (Giwercman et al. 1993). According
to a recent hypothesis, this trend might
derive from increasing exposure to endocrine
disrupters, such as POCs, during fetal life
(Toppari et al. 1996). It is a matter of grave
concern that the dioxin doses causing
decreased sperm counts in rats are less than
one order of magnitude higher than the aver-
age daily human dioxin intake from the diet.
It is not known whether lower body burdens
of POCs, corresponding to what occurs in
the general population of Western societies,
might pose a hazard to the male reproductive
function. Moreover, it is not known whether
POCs might impair semen function only
after exposure during the fetal and perinatal
period, or whether exposure during adult life
might also cause harmful effects.
Our aim in this study was to assess the
association between serum levels of CB-153
as an index substance for POC exposure, and
reproductive function parameters in young
males from the general Swedish population.
Subjects and Methods
Subjects and medical examination. Ap-
proximately 95% of all Swedish males
undergo a medical health examination before
military service. Only those with serious
chronic diseases are a priori excluded.
Therefore, the group of men that undergo the
conscript examination closely reﬂects the gen-
eral population of young Swedish males. A
total of 2,255 men born during the period
1979–1982 and living within an area of
60 km from the city of Malmö in southern
Sweden were asked to participate. Of these,
13.5% (n = 305) agreed to enter the study.
Their median age at the time of examination
was 18.1 years (range, 18–21 years).
All subjects underwent an andrologic exam-
ination, including measurement of testicular
volume by use of ultrasound. The information
on their height and weight—as assessed at the
compulsory medical examination before the
military service—was used for calculation of
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A time-related deterioration in male reproductive function caused by exposure to endocrine dis-
rupters, including persistent organochlorines (POCs), has been hypothesized. In animal studies,
POCs were found to have adverse effects on male reproductive function. However, little is known
about the impact of POC exposure on reproductive parameters in men. In a study of 305 young
Swedish men 18–21 years old from the general population, we correlated lipid-adjusted serum lev-
els of 2,2´,4,4´,5,5´-hexachlorobiphenyl (CB-153)—an index substance for POC exposure—to
markers of male reproductive function: testis size assessed by ultrasound, sperm concentration,
total sperm count, sperm motility assessed manually and with a computer-aided sperm analyzer
(CASA), and serum levels of follicle-stimulating hormone, inhibin B, testosterone, sexual hor-
mone–binding globulin (SHBG), luteinizing hormone, and estradiol. We found weak but statisti-
cally significant, negative correlations between CB-153 levels and both the testosterone:SHBG
ratio (r = –0.25, p < 0.001)—a measure of the biologically active free testosterone fraction—and
CASA sperm motility (r = –0.13, p = 0.02). No statistically signiﬁcant association with other semi-
nal, hormonal, or clinical markers of male reproductive function was found. In previous studies of
more highly POC-exposed groups of adult men, the correlation between POC exposure, including
CB-153, and free testosterone levels was not statistically signiﬁcant. The present study gives some
tentative support for weak negative effects of CB-153 exposure on sperm motility and free testos-
terone levels in young men, but further semen studies on more highly exposed groups may give
more ﬁrm conclusions on the hazard for male reproductive function from dietary POC exposure.
Key words: dioxin, male reproduction, PCB, reproductive hormones, semen quality, sperm con-
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Research | Articlesthe body mass index (BMI, in kilograms per
square meter). Their present smoking habits
were recorded. Immediately after the examina-
tion, the subjects delivered a semen sample as
well as blood samples drawn from a cubital
vein. All subjects received a sum correspond-
ing to US$50 for their participation. The local
ethics committee approved the study, and all
subjects signed an informed consent form.
Ultrasound scanning. Ultrasound scan-
ning of the testes was performed in supine
position by use of a 7.5-MHz transducer con-
nected to an Aloka 900 SSE scanner (Aloka,
Tokyo, Japan). Each testis was investigated in
two projections, and the volume was calcu-
lated as length × width × depth × 0.52.
Hormone analysis. Circulating levels of
follicle-stimulating hormone (FSH), luteiniz-
ing hormone (LH), sexual hormone–binding
globulin (SHBG), testosterone, and estradiol
were measured on an automated ﬂuorescence
detection system (Autodelfia, Wallac Oy,
Turku, Finland) at the routine clinical chem-
istry laboratory, Uppsala University Hospital.
Intraassay and total assay variation were
below the level of 4.0 and 7.5%, respectively.
Inhibin B levels were assessed using a speciﬁc
immunometric assay, as previously described
(Groome et al. 1996), with a detection limit
of 15 ng/L and intraassay and total assay vari-
ation coefficients below 7%. The reference
levels for the hormone analyses are given in
Table 1.
Semen analysis. Each subject was asked to
provide in a room at the laboratory a semen
sample by masturbation into a wide-mouthed
plastic cup. Three of the 305 participants
were unable to produce an ejaculate; there-
fore, a total of 302 semen samples were
included in the study. The men were asked to
remain abstinent for at least 48 hr, but the
length of the actual abstinence period was
recorded (Table 1). The weight of the empty
plastic cup was subtracted from the total
weight of cup and semen to get the semen
volume (in milliliters). The measurements
were done by use of a Sartorius scale, and the
results were expressed with two decimals.
The semen samples were analyzed accord-
ing to the World Health Organization’s
(WHO) recommendations (WHO 1999).
Sperm concentration was assessed by use of a
modified Neubauer chamber (Developing
Health Technology, Barton Mills, UK), and
positive displacement pipettes were used for
proper dilution of the ejaculate. Only three
laboratory assistants performed the analyses of
the ejaculates, and the interobserver coefﬁcient
of variation was found to be 8.5% for concen-
tration assessment. According to the WHO
recommendations, for determination of sperm
motility, 200 spermatozoa were scored in cate-
gories A, B, C, and D, with A corresponding
to rapid progressive motility, B to slow pro-
gressive motility, C to nonprogressive motility,
and D to immotility. Because there is consid-
erable interobserver variation in discriminating
between A and B, these two scores were pooled
together. Previous studies have indicated that
the percentage of progressively motile sperma-
tozoa (A + B) is the most significant of the
WHO motility categories in relation to the fer-
tility potential of a male (Jouannet et al. 1988).
For that reason, and because the total sum of
scores A, B, C, and D will always be 100, the
category C was excluded from the analysis,
which was restricted to the two types of
motility, A + B and D.
Furthermore, the percentages of motile,
locally motile, and immotile spermatozoa were
assessed by use of CRISMAS computer-aided
sperm motility analyzer (CASA), as previously
described by Larsen et al. (Larsen et al. 2000).
Briefly, the analysis was performed in a 10-
µm Makler chamber at 37°C. The samples
were diluted, if necessary, in a phosphate
buffer. The motility assessment was based on
capture sequences of 64 images (25 MHz),
and for each sample at least 100 spermatozoa
were analyzed. The designation of the motil-
ity status was based on the level of the curvi-
linear velocity, with > 25 µm/sec for motile
spermatozoa, 5–25 µm/sec for locally motile,
and > 5 µm/sec for immotile spermatozoa.
Because of technical problems, ejaculates
from only 285 of the 302 ejaculates were
available for CASA analysis. However, the 17
subjects excluded from the CASA analysis did
not differ significantly from the remaining
285 in sperm concentration or serum levels of
CB-153.
Determination of CB-153. CB-153 was
analyzed according to a modiﬁed method of
Janak et al. (Janak et al. 1999). One milliliter
of serum was added with 50 µL internal stan-
dard methanol solution containing 20 ng of
13C12-labeled CB-153/mL (Cambridge
Isotope Laboratories, Andover, MA, USA).
Preparation of external standards was per-
formed by addition of different amounts of
unlabeled CB-153 (Cambridge Isotope
Laboratories) to 1.0 mL blank serum. The
standard curve was corrected for the original
contents of CB-153 in the blank serum. After
the addition of the standards, the serum was
stored at 4°C overnight.
The next morning, 2 mL formic acid:2-
propanol (4:1) mixture was added to the
serum samples. The sample was sonicated in
an ultrasonic bath for 5 min. After about
30 min, 2 mL water:2-propanol (17:3) was
added and the sample was sonicated again for
5 min. Isolute ENV+ (200 mg; 6 mL;
International Sorbent Technology, Hengoed,
UK) solid-phase extraction (SPE) columns
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Table 1. Andrological parameters, and CB-153 and hormonal levels in young men from the general
Swedish population.
Parameter Reference interval No. Mean (SD) Median Range
CB-153 (ng/g lipid) NA 305 68 (29) 65 23–250
BMI (kg/m2) 18.5–24.9a 305 22 (3.2) 22 15–42
Abstinence period (hr) NA 302 85 (57) 67 12–504
Total testis volume (mL) NA 305 29 (7.7) 29 13–53
Semen volume (mL) > 2.0b 302 3.2 (1.3) 3.2 0.3–8.4
Sperm concentration (× 106/mL) > 20.0b 302 72 (66) 54 0.1–390
Total sperm count (× 106)>   40b 302 210 (180) 167 0.5–1,200
Sperm motility (%)
A + B > 50b 302 54 (17) 56 0–85
DN A 302 31 (13) 29 6–99
CASA motile NA 285 51 (22) 51 0–100
CASA immotile NA 285 32 (23) 29 0–100
Inhibin B (ng/L) 100–240c 305 210 (62) 200 54–420
FSH (IU/L) 1.0–10.51c 305 3.5 (1.5) 3.0 0.5–12.5
LH (IU/L) 1.2–9.6c 305 4.2 (1.8) 4.2 1.2–10.2
Testosterone (nM) 8.7–33c 305 23 (5.3) 23 6.1–38
SHBG (nM) 13–50c 305 28 (9.7) 28 7.2–67
Testosterone:SHBG NA 305 1.0 (0.5) 1.2 0.1–2.1
Estradiol (pM) 60–150c 305 80 (17) 77 43–144
NA, not available.
aAs recommended by WHO. bAccording to WHO (1999). cClinical reference values for the laboratory performing the analyses.
Table 2. Pearson's r for CB-153 serum concentra-
tions and reproductive parameters among young
men from the general Swedish population.
CB-153
(ng/g lipid)
Parameter No. rp -Value
Total testis volume (mL) 305 0.02 0.7
Semen volume (mL) 302 –0.01 0.4
Sperm concentration (× 106/mL) 302 < 0.01 1.0
Total sperm count (× 106) 302 < 0.01 1.0
Sperm motility (%)
A + B 302 –0.09 0.14
D 302 0.11 0.05
CASA motile 285 –0.13 0.02
CASA immotile 285 0.11 0.06
Inhibin B (ng/L) 305 0.02 0.7
FSH (IU/L) 305 0.09 0.1
LH (IU/L) 305 –0.04 0.5
Testosterone (nM) 305 0.05 0.4
SHBG (nM) 305 0.25 < 0.001
Testosterone:SHBG 305 –0.25 < 0.001
Estradiol (pM) 305 –0.14 0.01were conditioned by 1 mL methanol, 6 mL of
dichloromethane (DCM), 5 mL methanol,
and 3 mL water. The columns were mounted
on a VacMaster-20 sample-processing station
equipped with Teflon combined stopcock
needles (International Sorbent Technology).
Thirty minutes after the sonification of the
serum samples, these were applied to the
columns. The maximum flow rate of serum
samples through the SPE column was
1 mL/min. The SPE columns were thereafter
washed with 4 mL water:2-propanol (19:1)
and with 2.5 mL water:methanol (9:1) at a
flow rate up to 10 mL/min. The columns
were dried with air suction for about 20 sec.
One milliliter of concentrated sulfuric acid at
a flow rate of 0.2 mL/min was then applied
to the columns, after which these were
washed with 2.5 mL water, 1.0 mL 1 M
Na2CO3, 2.5 mL water, and 2.5 mL of
water:methanol (9:1). Three drops of
water:methanol (3:7, vol/vol) were added and
the columns were dried with air suction for
about 3 min. The columns were then cen-
trifuged at 1,500g for 10 min and then again
dried with air suction for 5 min. The CB-153
was eluted with 2 mL DCM, which was then
evaporated and dissolved in 100 µL of
toluene.
The samples were analyzed by gas chro-
matography–mass spectrometry (GC-MS).
The equipment consisted of a VG Trio 1000
quadrupole MS (Fisons, Manchester, UK)
and a Carlo-Erba 8065 GC equipped with an
A200S autosampler (Carlo-Erba, Milan,
Italy). The column was a fused silica capillary
column (30 m × 0.25 mm inner diameter)
with a DB-5 MS stationary phase and a ﬁlm
thickness of 0.25 µm (J&W Scientific,
Folsom, CA, USA). The samples were ana-
lyzed by a splitless injection technique. The
injector temperature was kept at 300°C, and
the injection volume was 2.0 µL. The initial
column temperature was 100°C for 1 min.
The temperature was thereafter increased by
15°C/min to 300°C. The MS interface was at
300°C, and the ion source was at 130°C. The
MS was in the negative ion chemical ioniza-
tion mode with ammonia as moderating gas.
Selected ion monitoring of CB-153 was per-
formed at m/z 326 and 360, whereas m/z 338
and 372 were chosen for the labeled internal
standard.
The relative standard deviations, calculated
from samples analyzed in duplicate at different
days, were 7% at 0.6 ng/mL (n = 76) and 5%
at 1.5 ng/mL (n = 37). The detection limit was
< 0.05 ng/mL. The analysis of CB-153 is part
of the Round Robin intercomparison program
(H. Drexler, Institute and Out-patient Clinic
for Occupational, Social and Environmental
Medicine, University of Erlangen-Nuremberg)
with analysis results within the reference limits.
Determination of lipids by enzymatic
methods. Plasma concentrations of triglyc-
erides, cholesterol, and phospholipids were
determined by enzymatic methods using
reagents from Boehringer-Mannheim (triglyc-
erides and cholesterol; Mannheim, Germany)
and Waco Chemicals (phospholipids; Neuss,
Germany). The total lipid concentration in
plasma was calculated by summation of the
amounts of triglycerides, cholesterol, and phos-
pholipids. In these calculations, the average
molecular weights of triglycerides and phos-
pholipids were assumed to be 807 and 714,
respectively. For cholesterol, we used an aver-
age molecular weight of 571, postulating that
the proportion of free and esteriﬁed cholesterol
in plasma was 1:2.
Statistical analysis. Bivariate associations
between concentrations of lipid-adjusted CB-
153 in serum and total testis volume, semen
volume, sperm concentration, total sperm
count, sperm motility, and inhibin B, FSH,
LH, testosterone, SHBG, testosterone/
SHBG, and estradiol levels, respectively, were
evaluated by Pearson’s correlation coefﬁcient.
To ensure that linear associations were reason-
able (and accordingly the use of Pearson’s r),
scatter plots were assessed for all bivariate
comparisons. The effects of CB-153 on the
sperm and the hormone levels were evaluated
by linear regression models, adjusting for
potential confounders. Model assumption
was checked by means of residual analysis.
CB-153 was treated as a continuous variable
as well as categorized into three equally sized
groups (< 53.9, 53.9–74.6, > 74.6 ng/g
lipid). As potential confounders, BMI,
length of abstinence period (treated as a con-
tinuous variable and alternatively categorized
into four categories: < 49, 49–72, 73–96, and
> 96 hr), and smoking habits [smokers (n =
218) vs. nonsmokers (n = 87)] were consid-
ered. If the adjusted estimate differed less
than 15% from the crude estimate, we pre-
sent only the crude results. When trends in
the data were tested, the Jonckheere-Terpstra
test was applied.
Results
The testicular volume was not correlated with
the serum levels of CB-153.
A statistically significant negative, but
weak, correlation was found between the
CB-153 levels and the percentage of motile
cells assessed by CASA (Table 2, Figure 1).
The same pattern of correlations, close to
the level of statistical significance, was
observed also for conventional motility para-
meters. The estimated effects of changes in
CB-153 levels on sperm motility parameters
are shown in Table 3. Thus, an increase in
CB-153 levels by 10 ng/g lipid corresponded
to 1.0% decrease in the percentage of CASA
motile spermatozoa [95% confidence inter-
val (CI), –2.0 to –0.13; Table 3] and was
accompanied by an equal increase in the
percentage of immotile cells, a correlation
that was almost statistically significant. No
significant correlations were found between
the CB-153 levels and seminal volume,
sperm concentration, and total sperm count,
respectively (Table 2). In an alternative
analysis the CB-153 variable was categorized
into three equal-sized groups. No other
exposure–response associations than those
seen in the linear analyses appeared.
There was a signiﬁcant positive correlation
between serum levels of CB-153 and SHBG,
whereas the correlations were negative between
CB-153 and the testosterone:SHBG ratio, and
estradiol, respectively (Table 2). After adjust-
ment for BMI, which was clearly associated
with estradiol, testosterone, and the testos-
terone:SHBG ratio, the correlation between
CB-153 and estradiol was no longer statistically
signiﬁcant (Table 4). CB-153 was not correlated
with inhibin B, total testosterone, FSH, or LH.
Discussion
In the present study we found weak but sig-
nificant negative correlations between
CB-153 levels in serum and both CASA
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Figure 1. Correlation between the serum levels of
CB-153 and percentage of motile spermatozoa, as
assessed by CASA, in 285 young men from the
general Swedish population.


























Table 3. Estimated effects (β) of 10 ng/g lipid increase in CB-153 levels in serum on sperm motility parameters
among young men from the general Swedish population, obtained from linear regression analyses.
Sperm parameter No. Intercept β 95% CI
Sperm motility (%)
A + B 302 57 –0.50 –1.2, 0.16
D 302 27 0.52 –0.0068, 1.0
CASA motile 285 58 –1.0 –2.0, –0.13
CASA immotile 285 26 0.89 –0.057, 1.8sperm motility and the testosterone:SHBG
ratio—a measure of the biologically active
free testosterone fraction. The latter associa-
tion was due to a positive correlation between
the concentration of CB-153 and SHBG lev-
els, whereas no association with total testos-
terone was seen. Furthermore, no statistically
significant association with other seminal,
hormonal, or clinical markers of male repro-
ductive function was found, although the cor-
relations with other motility parameters were
almost significant. No congener other than
CB-153 was analyzed in the present study.
It is known from animal experiments that
relatively low doses of several POCs have neg-
ative impacts on male reproductive function
(Toppari et al. 1996). However, the knowl-
edge of adverse effects of POCs on the
human male reproductive function is still
limited. The present study is, to our knowl-
edge, the ﬁrst aiming to elucidate the impact
of levels of exposure to POCs, corresponding
to what occurs in general populations of
Western societies, on a broad range of para-
meters of male reproductive function.
Several POCs interact with hormonal
pathways and can therefore be considered
potential endocrine disrupters. Some PCB
congeners have estrogenic properties, whereas
dioxins and dioxin-like PCB have more of
antagonistic effects on the estrogen receptors
(Toppari et al. 1996). Other compounds,
such as the main p,p´-dichlorodiphenyl-
trichloroethane (DDT) metabolite 1,1-
dichloro-2,2-bis(p-chlorophenyl)ethylene
(DDE), are anti-androgenic. Hepatic synthe-
sis of SHBG is known to be affected by the
estrogen–androgen balance, and ﬁnding of a
positive correlation between CB-153 levels
and SHBG might be due to the estrogenic or
anti-androgenic properties of the POCs, for
which CB-153 serves as a proxy marker.
Furthermore, the increase in SHBG concen-
tration—by rising serum CB-153—was not
accompanied by rising testosterone levels,
which implies a lower free testosterone frac-
tion and thereby reduced androgenic activity.
We found that an increase in CB-153
levels with 10 ng/g lipid implied a 1%
decrease in the percentage of motile sperma-
tozoa as assessed by CASA. Interestingly, in
a study based on Danish first pregnancy
planners, percentage of motile spermatozoa
as assessed by CRISMAS CASA, but not
manually, was found to be an independent
predictor of the fecundity of the couple
(Bonde et al. 1998; Larsen et al. 2000).
CASA analysis of sperm motility is subject
to a lesser degree of intralaboratory variation
than is the manual analysis (Auger et al.
2000; Boone et al. 2000; Jørgensen et al.
1997) and may therefore be a more sensitive
measure of male fertility.
We did not ﬁnd any correlation between
CB-153 levels and the other important seminal
predictor of fertility (Bonde et al. 1998)—
sperm concentration. However, in a recent
study, an impairment of sperm motility—
without changes in daily sperm production or
morphology—was found in diethylstilbestrol-
treated adult rats (Goyal et al. 2001). In
another report (van Birgelen et al. 1999), 13
weeks of exposure of 4-week-old rats to
3,3´,4,4´-tetrachloroazoxybenzene, a contami-
nant of 3,4-dichloroaniline and the anilide
herbicide Diuron, which acts through the aryl
hydrocarbon receptor in a dioxin-like manner,
decreased the motility but not the concentra-
tion of the epididymal spermatozoa. The
opposite effect was found in mice, and neither
species reached a no-observed-adverse-effect
level. A small semen-quality study of teenagers
who had been substantially exposed in utero,
because of ingestion of POCs by their mothers
via contaminated cooking oil, did show
increased percentages of morphologically
abnormal cells as well as reduced motility and
ability to penetrate hamster oocytes compared
with spermatozoa from control subjects (Guo
et al. 2000). In another study, levels of some
PCB congeners have been shown to be
inversely correlated with sperm motility in
semen samples in which sperm concentration
was below 20 million/mL (Bush et al. 1986).
In a small pilot study of 29 men presenting to
a U.S. andrology laboratory for semen evalua-
tion, there were indications that those subjects
with normal sperm concentrations, motility,
and morphology had somewhat lower serum
concentrations of total PCB and p,p´-DDE,
compared with the others (Hauser et al. 2002).
The serum concentrations of CB-153 were
very similar to those observed in the present
study. Thus, previous studies have already
indicated that POCs can induce negative
effects on male reproductive health, including
deterioration of semen characteristics, also in
humans. However, the key questions are what
doses are needed for causing such effects, and
whether the body burdens in the general popu-
lation, which almost exclusively derive from
the diet, are sufﬁciently high for impairing the
male reproductive function.
A positive correlation between POC
exposure and SHBG levels was also found in
110 Swedish and Latvian adult men, but after
age adjustment, the correlation was no longer
signiﬁcant (Hagmar et al. 2001). It should be
noticed that the CB-153 levels in serum from
the men in the present study were low, with a
median value of 65 ng/g lipids (range,
23–250). This can be compared with median
levels, in samples collected in 1991, of 450
ng/g lipids for adult Swedish men with a high
consumption of fatty ﬁsh from the Baltic Sea,
410 for those with more moderate fish con-
sumption habits, and 220 for those with no
such consumption (Sjodin et al. 2000).
However, the lack of a signiﬁcant association
between CB-153 and SHBG levels in the
more highly exposed men might at least be
due to a lower statistical power compared
with the present study of 305 men, in which
age correction was not necessary because
of a similar age of all the participants.
Furthermore, given that the male reproduc-
tive system is most sensitive to the effect of
endocrine disrupters during early fetal or
perinatal life (Sharpe et al. 1993), the CB-
153 values obtained at adult age may not nec-
essarily express the level of exposure at that
critical time window of development.
However, the lack of coherence among
the studies calls for caution. A possibility that
cannot be excluded is that weak associations
observed in the present study were chance
findings. It is therefore important to try to
assess these associations in other populations
as well. A study among subjects with higher
and more varying body burdens of POCs
may clarify this matter.
It can be assumed that the cohort of 305
young men included in this study is represen-
tative for this age group of men in southern
Sweden, despite the fact that only 13.5% of
eligible subjects agreed to deliver a semen
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Table 4. Estimated effects (β) on hormone levels by 10 ng/g lipid increase in CB-153 concentrations in serum and BMI in 305 young men from the general Swedish
population, obtained from linear regression analyses.
SHBG (nmol/L) Estradiol (pmol/L)
Crude Adjusteda Crude testosterone/SHBG Crude Adjusteda
Parameter β 95% CI β 95% CI β 95% CI β 95% CI β 95% CI
Intercept 23 42 1.0 85 74
CB-153 (ng/g lipid) 0.84 (0.47–1.21) 0.56 (0.18–0.94) –0.024 (–0.035––0.013) –0.82 (–1.5––0.17) –0.66 (–1.4–0.028)
Intercept 50 — 0.51 65 —
BMI (kg/m2) –0.93 (–1.3––0.61) –0.77 (–1.1–0.42) 0.016 (0.0061–0.026) 0.66 (0.067–1.3) 0.46 (–0.16–1.1)
If the adjusted estimate differed < 15% from the crude estimate, we present only the crude results.
aEstimated when CB-153 and BMI simultaneously were included in the model.sample. It cannot be expected that men 18–21
years old have any knowledge about their
reproductive capability. The low participation
rate should therefore not imply any selection
bias with respect to fertility. Accordingly, in a
recent Danish conscript study, with a corre-
spondingly low participation rate, it was con-
cluded that the participants seemed to be
representative for the whole group of con-
scripts, based on the levels of reproductive
hormones in participants and nonparticipants
in the semen study (Andersen et al. 2000).
We found the same mean BMI for the group
of men delivering semen samples in the pre-
sent study as was found for the whole group
of Swedish young men who had taken part in
the conscript examination. This is also an
indication that the sampled group was repre-
sentative for the total group. Furthermore, it
seems unlikely that the level of exposure to
CB-153 had any effect on whether a subject
agreed to participate in the study. No associa-
tions were found between the length of absti-
nence period and the motility and hormone
variables, respectively. Therefore, length of
abstinence period was not a confounder for
these outcome measures.
In conclusion, the present study gives
some tentative support for weak negative
effects of CB-153 exposure on sperm motility
and free testosterone levels in young men.
Previous findings of the lack of correlation
between POC exposure and free testosterone
levels in more highly exposed adult men sup-
ports the possibility that the present results
might be chance findings. Future studies of
reproductive function on more highly POC-
exposed groups are needed in order to draw
more ﬁrm conclusions.
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